Graphic: medical AI accuracy shown as a target of blue rings with a gold centre

Medical AI Accuracy: What a $15 Billion Valuation Does Not Prove

Medical AI accuracy is the question that a reported $15 billion valuation for OpenEvidence leaves open. Reports from late September 2026 say the AI medical search company raised $250 million at that value, but a funding round measures investor expectations, not how often an AI answer is right. This explainer sets out what accuracy means for tools doctors use to look up evidence, why it is hard to measure, how clinicians and patients can judge an AI answer, and which questions to ask about any such product. It is general information and not medical advice.

Medical AI accuracy: key takeaways

  • Funding, valuation and usage numbers say nothing about whether answers are correct.
  • The reports we reviewed give no independent accuracy data for OpenEvidence; the company reportedly links answers to sources so users can check them.
  • Accuracy has several parts: finding the right evidence, summarising it faithfully and applying it to the right patient.
  • A clinician remains responsible for decisions made with any AI tool.
  • Patients should not use AI answers in place of advice from their doctor.

What medical AI accuracy means

General background: for a tool that answers medical questions, accuracy is not one number. It includes whether the facts stated are true, whether the answer reflects current guidelines, whether the cited source actually supports the claim, and whether important cautions are left out. An answer can be factually correct but unhelpful if it misses the patient’s situation, such as age, kidney function or pregnancy. That is why developers and independent researchers usually test several of these dimensions separately.

What the reported valuation does and does not show about medical AI accuracy

The reports say OpenEvidence raised $250 million at a $15 billion valuation, up from $12 billion in January, and that more than 40% of US physicians use it, according to company-stated figures in one report. These numbers show interest and adoption. They do not show error rates, and a tool can be popular and still be wrong in particular cases. We could not find a company confirmation of the round in the material we reviewed, and no independent accuracy study was cited. The OpenEvidence site describes the product but is not an independent test.

Why medical AI accuracy is hard to measure

General background: medicine changes, guidelines differ between countries, and many questions have no single right answer. Tests that use exam-style questions can overstate real-world performance, because clinicians ask messy, context-heavy questions. Models can also produce fluent text that sounds confident when it is wrong. Reliable testing therefore needs real clinician questions, expert grading, regular re-testing as models and evidence change and clear reporting of failures, not only averages.

How citations help, and where they fall short

This section is our analysis. A tool that links each statement to a source lets a clinician check it in seconds, which is a real safety feature. But citations do not guarantee accuracy: a link may point to a paper that does not say what the summary claims, or to a low-quality study, or the tool may omit a contradicting source. Checking the source for the one or two claims that would change a decision is a sensible habit, especially for dosing, interactions and high-risk situations.

Advertising and trust in medical AI accuracy

The reports say the service is free to physicians and earns revenue from advertising aimed at medical professionals and other commercial relationships. General background: any ad-supported medical information source should make clear how advertising is separated from answers, because clinicians and patients may reasonably want to know whether commercial relationships can influence what is shown. We did not find a description of the company’s policy in the reports we reviewed, and we draw no conclusion about it.

Questions to ask about any medical AI tool

  • Has an independent group tested its answers, and are the results published?
  • Does it show sources for each claim, and are they current guidelines or studies?
  • How does it handle uncertainty and questions it cannot answer?
  • Is it regulated, and under which rules? See the FDA guidance on clinical decision support software for when decision-support software counts as a device.
  • How is advertising separated from the answers?

What patients should keep in mind about medical AI accuracy

General background: tools built for physicians are not designed for the public, and the information may assume training that patients do not have. If you see an AI-generated answer about your condition, use it to prepare questions and not to change treatment. Bring the source to your doctor and ask what it means for you. The WHO guidance on the ethics and governance of artificial intelligence for health discusses transparency and accountability principles for health AI, which are useful when judging claims about accuracy.

What is not disclosed about medical AI accuracy

  • Independent accuracy and safety testing of OpenEvidence in the reports we reviewed.
  • Company confirmation of the funding and valuation.
  • How often clinicians change decisions based on its answers.
  • Its advertising and independence policies.

Risks and caveats on medical AI accuracy

  • Popularity and funding are not evidence of correctness.
  • Reports of the round rely on unnamed sources.
  • AI answers can be wrong or incomplete, even with citations.
  • This is general information, not medical advice.

In our assessment, medical AI accuracy is the measure that matters most for tools like OpenEvidence, and until independent results are published, readers should treat the valuation as a signal about business, not about quality. See also Johns Hopkins Medicine Partners With OpenEvidence on AI Clinical Care and Medical Education. See also OpenEvidence Introduces Four Medical AI Models with Different Levels of Clinical Research Depth. More in our healthcare IT coverage.

What to watch next on medical AI accuracy

  • Independent studies of AI medical search tools.
  • Company confirmation of the round and any disclosure of testing.
  • Regulatory guidance on decision-support software.

Frequently asked questions

Does a high valuation mean a medical AI is accurate?

No. It reflects investor expectations and not tested performance.

How can doctors check an AI answer?

By opening the cited source and checking that it supports the claim, especially for high-risk decisions.

Should patients rely on these tools?

No. Use them to prepare questions and talk to your doctor before any change in treatment.

How we reported this: we relied on published reports from September 2026, the company website and public guidance from regulators and the WHO. General background and our analysis are labelled. Last updated: 22 October 2026. This article is news reporting and education and not medical advice.

Leave a Comment

Comments

No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *